PHARMADAN A/S — Credit Rating and Financial Key Figures
CVR number: 26524938
Englandsvej 350-356, 2770 Kastrup
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -1 761.24 | -2 844.19 | -3 128.26 | -4 923.09 | -5 840.52 |
| Total depreciation | - 318.04 | - 314.05 | - 311.71 | - 291.53 | - 233.41 |
| EBIT | -2 079.28 | -3 158.24 | -3 439.98 | -5 214.62 | -6 073.93 |
| Other financial income | 7.00 | 20.50 | |||
| Other financial expenses | -2.35 | -61.31 | - 109.84 | - 190.24 | - 481.98 |
| Pre-tax profit | -2 074.63 | -3 219.55 | -3 529.32 | -5 404.86 | -6 555.91 |
| Income taxes | 456.42 | 708.30 | 776.45 | 1 237.18 | 1 442.30 |
| Net earnings | -1 618.21 | -2 511.25 | -2 752.87 | -4 167.68 | -5 113.61 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 1 303.77 | 989.72 | 785.03 | 493.50 | 262.55 |
| Tangible assets total | 1 303.77 | 989.72 | 785.03 | 493.50 | 262.55 |
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 1 262.81 | 955.91 | 800.00 | 1 655.47 | 2 201.67 |
| Inventories total | 1 262.81 | 955.91 | 800.00 | 1 655.47 | 2 201.67 |
| Current trade debtors | 567.69 | 253.85 | 179.91 | 400.38 | 938.65 |
| Prepayments and accrued income | 36.40 | 38.60 | 57.89 | 53.24 | |
| Current deferred tax assets | 145.50 | 790.27 | 917.43 | 1 910.04 | 3 352.34 |
| Short term receivables total | 749.59 | 1 082.72 | 1 097.34 | 2 368.31 | 4 344.22 |
| Cash and bank deposits | 6.42 | 84.94 | 0.51 | 0.41 | 13.39 |
| Cash and cash equivalents | 6.42 | 84.94 | 0.51 | 0.41 | 13.39 |
| Balance sheet total (assets) | 3 322.59 | 3 113.29 | 2 682.87 | 4 517.69 | 6 821.83 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 600.00 | 600.00 | 600.00 | 600.00 | 600.00 |
| Retained earnings | 2 035.14 | 416.93 | -2 094.32 | -4 847.19 | -9 014.87 |
| Profit of the financial year | -1 618.21 | -2 511.25 | -2 752.87 | -4 167.68 | -5 113.61 |
| Shareholders equity total | 1 016.93 | -1 494.32 | -4 247.19 | -8 414.87 | -13 528.48 |
| Non-current liabilities total | |||||
| Current trade creditors | 119.64 | 262.33 | 208.72 | 256.07 | 221.26 |
| Current owed to group member | 2 095.69 | 4 332.32 | 6 692.27 | 12 668.67 | 20 117.91 |
| Other non-interest bearing current liabilities | 90.32 | 12.95 | 12.95 | 7.83 | 11.14 |
| Accruals and deferred income | 16.12 | ||||
| Current liabilities total | 2 305.66 | 4 607.61 | 6 930.06 | 12 932.56 | 20 350.31 |
| Balance sheet total (liabilities) | 3 322.59 | 3 113.29 | 2 682.87 | 4 517.69 | 6 821.83 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.